Art

J-GLOBAL ID：201402240008252818   Reference number：14A0952371

血小板数増加とLDH高値にて紹介された1例

Author (3)： OKAMOTO SHUICHIRO (川崎医大 医 臨床医学 検査診断学) ,  OKAMOTO SHUICHIRO (生長会 府中病院 血液疾患セ) ,  TOOYAMA KAORU (川崎医大 医 臨床医学 検査診断学)
Material： 日本検査血液学会雑誌  (検査と血液)
Volume： 15  Issue： 2  Page： 200-207  Publication year： Jul. 31, 2014 
JST Material Number： L4223A  ISSN： 1347-2836  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *blood platelet disorder ,...
Semi thesaurus term： JAK2 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0952371&from=J-GLOBAL&jstjournalNo=L4223A") }}

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Clinical oncology in general  (GE03010Y)

Substance index (6)： Idarubicin ,  Cyclophosphamid ,  Cytarabine ,  Busulfan ,  Mitoxantrone ,  CC-5013

Reference (11)：

• Vardiman JW, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. ed Swerdlow S.H, et al, p85-86, International Agency for Research on Cancer, Lyon 2008.
• Hasserjian RP, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. ed Swerdlow S.H, et al, p102, International Agency for Research on Cancer, Lyon 2008.
• Ingram W, et al: The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow. Leukemia 20: 1319-1321, 2006.
• Patmaik MM, et al: WHO-defined ‘myelodysplastic syndrome with isolated del (5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutation. Leukemia 24: 1283-1289, 2010.
• Arber DA, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. ed Swerdlow S.H, et al, p124-126, International Agency for Research on Cancer, Lyon 2008.

Terms in the title (2)： 血小板数 ,  LDH